Aoife M. Brennan's Insider Trades & SAST Disclosures
Aoife M. Brennan's most recent trade in Climb Bio Inc. was a trade of 1,150,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 13, 2025.
Add Superstar Alert
Note
This is a custom search result for pattern Aoife M. Brennan.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
|
Climb Bio Inc.
|
Aoife M. Brennan | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2025 | 1,150,000 | 1,150,000 | - | - | Stock Option (Right to Buy) | |
|
Climb Bio Inc.
|
Aoife M. Brennan | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2024 | 550,000 | 550,000 | - | - | Stock Option (Right to Buy) | |
|
Climb Bio Inc.
|
Aoife M. Brennan | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2024 | 275,000 | 275,000 | - | - | Restricted Stock Units | |
|
Xilio Therapeutics Inc
|
Aoife M. Brennan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
|
FibroGen Inc
|
Aoife M. Brennan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 70,000 | 70,000 | - | - | Stock Option (Right to Buy) | |
|
FibroGen Inc
|
Aoife M. Brennan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 12,666 | 12,666 | - | - | Stock Option (Right to Buy) | |
|
FibroGen Inc
|
Aoife M. Brennan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 8,289 | 32,680 (0%) | 0% | 0 | Common Stock | |
|
FibroGen Inc
|
Aoife M. Brennan | Director | Sale of securities on an exchange or to another person at price $ 17.52 per share. | 07 Jun 2023 | 2,739 | 27,947 (0%) | 0% | 17.5 | 47,987 | Common Stock |
|
FibroGen Inc
|
Aoife M. Brennan | Director | Sale of securities on an exchange or to another person at price $ 16.74 per share. | 07 Jun 2023 | 1,994 | 30,686 (0%) | 0% | 16.7 | 33,380 | Common Stock |
|
Synlogic Inc
Board Meeting |
Aoife M. Brennan | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 0.58 per share. | 03 Apr 2023 | 19,042 | 256,301 (0%) | 0% | 0.6 | 10,964 | Common Stock |
|
FibroGen Inc
|
Aoife M. Brennan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 25,684 | 25,684 | - | - | Stock Option (Right to Buy) | |
|
FibroGen Inc
|
Aoife M. Brennan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 15,777 | 24,391 (0%) | 0% | 0 | Common Stock | |
|
Synlogic Inc
Board Meeting |
Aoife M. Brennan | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 2.45 per share. | 04 Apr 2022 | 8,894 | 275,343 (0%) | 0% | 2.4 | 21,754 | Common Stock |
|
Synlogic Inc
Board Meeting |
Aoife M. Brennan | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2022 | 434,160 | 434,160 | - | - | Stock Option (right to buy) | |
|
Synlogic Inc
Board Meeting |
Aoife M. Brennan | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2022 | 106,920 | 284,237 (0%) | 0% | 0 | Common Stock | |
|
FibroGen Inc
|
Aoife M. Brennan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2021 | 7,800 | 7,800 | - | - | Stock Option (Right to Buy) | |
|
FibroGen Inc
|
Aoife M. Brennan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2021 | 4,700 | 8,614 (0%) | 0% | 0 | Common Stock | |
|
Synlogic Inc
Board Meeting |
Aoife M. Brennan | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2021 | 285,000 | 285,000 | - | - | Stock Option (right to buy) | |
|
Synlogic Inc
Board Meeting |
Aoife M. Brennan | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2021 | 71,250 | 177,317 (0%) | 0% | 0 | Common Stock | |
|
FibroGen Inc
|
Aoife M. Brennan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2020 | 10,400 | 10,400 | - | - | Stock Option (Right to Buy) | |
|
FibroGen Inc
|
Aoife M. Brennan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2020 | 6,496 | 6,496 | - | - | Stock Option (Right to Buy) | |
|
FibroGen Inc
|
Aoife M. Brennan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2020 | 3,914 | 3,914 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges